Alex Zhavoronkov, co-CEO of the AI drug discovery startup Insilico Medicine, dresses the same way at all his public engagements: a black padded vest with a small white badge that keeps count of the company’s clinical pipeline.
When Fortune sat down with him in Hong Kong in July, he made sure to point out the badge’s latest revision: a small circle beside “Phase 3.”